KNAPP THOMAS J enters ASCENTAGE PHARMA GROUP INTERNATIONAL with 362.44K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/23/2026ACC: 0001213900-26-033125
Officer· SVP/General Counsel
Since Mar 2026
362.44K
Baseline shares
100% direct
362.44K
Direct ownership
1 position
77.88K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned362.44K
Total
362.44K direct362.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 362.44K | Direct |
| Total | 362.44K | 362.44K direct |
Derivative Holdings2
Options
DirectUnderlying security
Ordinary Shares
Underlying shares
38.94K
Shares owned
N/A
Exercise price
8.14
Expiration
—
Exercise window
—
Restricted stock units
DirectUnderlying security
Ordinary Shares
Underlying shares
38.94K
Shares owned
N/A
Exercise price
0.00
Expiration
—
Exercise window
—
Total
Underlying
77.88K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Ordinary Shares | 8.14 | — | — | 38.94K | N/A |
| Restricted stock units Direct | Ordinary Shares | 0.00 | — | — | 38.94K | N/A |
| Total | 77.88K | 0.00 | ||||